Solitary morphea profunda (SMP) is a distinct form of localized scleroderma, a cutaneous disorder of unknown origin. Here, we describe a patient presenting with noninflammatory cupuliform depressed plaques, without any significant skin induration, pigmentation or texture change, that appeared on the left shoulder at a site of previous intramuscular vaccination. Light microscopy studies revealed excessive dermal collagen deposition with thickened hyalinized collagen bundles. Magnetic resonance imaging studies demonstrated tissue fibrosis with thinning of the subcutaneous fat tissue and involvement of the adjacent deltoid muscle, which was confirmed by electromyographic tests. Borrelia serology was negative. Our observation of SMP differed from previously described cases, since it mimicked localized lipoatrophy. Our observation highlights the wide spectrum of clinical presentations of localized scleroderma. The latter should be considered in the presence of lipoatrophy-like lesions for proper workup and therapy.

1.
Dancey AL, Waters RA: Morphea of the breast: two case reports and discussion of the literature. J Plast Reconstr Aesthet Surg 2006;59:1114–1117.
2.
Savoia P, Zaccagna A, Bernengo MG: Guess what? Inflammatory disseminated morphea profunda. Eur J Dermatol 1999;9:654–656.
3.
Melani L, Cardinali C, Giomi B, Schincaglia E, Caproni M, Fabbri P: Case study: periodic follow-up is necessary in morphea profunda to identify systemic evolution. Skinmed 2005;4:188–190.
4.
Whittaker SJ, Smith NP, Jones RR: Solitary morphoea profunda. Br J Dermatol 1989;120:431–440.
5.
Buchner SA, Rufli T: Morphaea profunda. Hautarzt 1990;41:155–157.
6.
Kirsner RS, Pardes JB, Falanga V: Solitary fibrosing paraspinal plaque: solitary morphoea profunda? Br J Dermatol 1993;128:99–101.
7.
Ahn S, Won JH, Choi EH, et al: Perforating plate – like osteoma cutis in a man with solitary morphea profunda. Br J Dermatol 1996;134:949–952.
8.
Kawakami T, Soma Y, Baba T, et al: Immunohistochemical analysis of transforming growth factor β3 expression in solitary morphoea profunda with histological membranocytic changes. Br J Dermatol 2002;146:171–173.
9.
Azad J, Dawn G, Shaffrali FC, Holmes SC, Barnetson RJ, Forsyth A: Does solitary morphoea profunda progress? Clin Exp Dermatol 2004;29:25–27.
10.
Blaszczyk M, Krysicka-Janiger K, Jablonska S: Primary atrophic profound linear scleroderma: report of three cases. Dermatology 2000;200:63–66.
11.
Sayama K, Chen M, Shiraishi S: Morphea profunda. Int J Dermatol 1991;30:873–875.
12.
Julian CG, Bowers PW: Osteoma cutis in a lesion of solitary morphoea profunda. Clin Exp Dermatol 2003;28:673–674.
13.
Diseases of connective tissue; in Braun-Falco O, Plewig G, Wolff HH, Burgdorf W (eds): Dermatology. Berlin, Springer, 2002, pp 785–795.
14.
Wojas-Pelc A, Wielowieyska-Szybinska D, Kieltyka A: Presence of the antinuclear antibodies and antibodies to Borrelia burgdorferi among patients with morphea en plaque, deep linear scleroderma and atrophoderma Pasini-Pierini. Przegl Lek 2002;59:898–902.
15.
Torrelo A, Suarez J, Colmenero I, Azorin D, Perera A, Zambrano A: Deep morphea after vaccination in two young children. Pediatr Dermatol 2006;23:484–487.
16.
Hehn J, Hartmann K, Bröcker EB, Goebeler M: Influenza-Schutzimpfung und Dermatosen – Koinzidenz oder kausale Assoziation? J Dtsch Dermatol Ges 2003;1:99–104.
17.
Park JH, Lee CW: Concurrent development of dermatomyositis and morphoea profunda. Clin Exp Dermatol 2002;27:324–327.
18.
Lupton GP, Goette DK: Localized eosinophilic fasciitis. Arch Dermatol 1979;115:85–87.
19.
Kencka D, Blaszczyk M, Jablonska S: Atrophoderma Pasini-Pierini is a primary atrophic abortive morphea. Dermatology 1995;190:203–206.
20.
Choffray A, Pinquier L, Bachelez H: Exacerbation of lupus panniculitis following anti-hepatitis-B vaccination. Dermatology 2007;215:152–154.
21.
Yamamoto T, Yokozeki H, Nishioka K: Localized involutional lipoatrophy: report of six cases. J Dermatol 2002;29:638–643.
22.
Dahl PR, Zalla MJ, Winkelmann RK: Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol 1996;35:523–528.
23.
Sunderkotter C, Kuhn A, Hunzelmann N, Beissert S: Phototherapy: a promising treatment option for skin sclerosis in scleroderma? Rheumatology 2006;45(suppl 3):iii52–iii54.
24.
Sawada H, Isogai Z, Morita A: Altered decorin expression of systemic sclerosis by UVA1 (340–400 nm) phototherapy: immunohistochemical analysis of 3 cases. BMC Dermatol 2003;3:2.
25.
Quan T, He T, Kang S, Voorhees JJ, Fisher GJ: Connective tissue growth factor: expression in human skin in vivo and inhibition by ultraviolet irradiation. J Invest Dermatol 2002;18:402–408.
26.
Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M: Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997;350:1295–1296.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.